Published in Am Rev Respir Dis on May 01, 1984
Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax (1990) 2.43
Difficult asthma. BMJ (1989) 2.28
Inhalation therapy in asthma. J R Soc Med (1992) 2.01
Adverse effects of inhaled corticosteroids. BMJ (1989) 1.91
Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. Thorax (1999) 1.91
Optimizing inhaled drug delivery in patients with asthma. Br J Gen Pract (1995) 1.70
Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate. Br J Clin Pharmacol (1999) 1.63
New perspectives on inhaled drug delivery and systemic bioactivity. Thorax (1995) 1.43
Aerosol therapy in Canada: what are the standards? CMAJ (1993) 1.38
Controlled trial of budesonide given by the nebuhaler in preschool children with asthma. BMJ (1988) 1.22
Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax (1993) 1.18
Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax (1996) 1.06
Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci (2012) 0.95
Respiratory and allergic disease. I. Br Med J (Clin Res Ed) (1988) 0.90
Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs? Br J Clin Pharmacol (2000) 0.87
Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler. Br J Clin Pharmacol (2008) 0.85
Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function. Thorax (1993) 0.85
In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler. Br J Clin Pharmacol (2009) 0.85
Differences in aerodynamic particle size distributions of innovator and generic beclomethasone dipropionate aerosols used with and without a large volume spacer. Thorax (1995) 0.75
Spacer devices increase dose of inhaled corticosteroids delivered. BMJ (1999) 0.75
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. Ther Clin Risk Manag (2008) 0.75
Should bronchodilators be combined in chronic bronchitis and emphysema? Br Med J (Clin Res Ed) (1987) 0.75
Long-term management of reversible obstructive airways disease in adults. Lung (1990) 0.75
The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain (1989) 5.59
Decisions near the end of life: professional views on life-sustaining treatments. Am J Public Health (1993) 4.27
Sources of concern about the Patient Self-Determination Act. N Engl J Med (1991) 3.90
The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain (1989) 2.59
A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene (2000) 2.35
The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain (1991) 2.11
Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis (1992) 2.02
The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain (2006) 1.92
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain (1999) 1.91
Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur Respir J (1993) 1.65
Hospital readmission after cardiac surgery. Does "fast track" cardiac surgery result in cost saving or cost shifting? Circulation (1998) 1.61
A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol (1977) 1.43
Directive counseling on long-acting contraception. Am J Public Health (1996) 1.38
Clinical use of spacer systems for corticosteroid inhalation therapy: a preliminary analysis. Eur J Respir Dis Suppl (1982) 1.37
Tetanus Immunization. Can Med Assoc J (1958) 1.35
Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis (1990) 1.31
The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain (1999) 1.30
Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol (1980) 1.28
Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J (1996) 1.27
The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. Brain (1991) 1.25
Passive smoking and low birthweight. Lancet (1989) 1.21
Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab (1991) 1.21
Budesonide: a new corticosteroid in bronchial asthma. Eur J Respir Dis (1980) 1.19
Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol (1982) 1.18
The Trendelenburg position: hemodynamic effects in hypotensive and normotensive patients. Crit Care Med (1979) 1.15
Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol (1991) 1.10
Phenytoin-theophylline interaction. N Engl J Med (1982) 1.10
The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis. Brain (2000) 1.10
Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med (1998) 1.09
Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol (1991) 1.07
An evaluation of the workplace smoking bylaw in the city of Toronto. Am J Public Health (1993) 1.06
Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis (1984) 1.06
Liver resection with the continuous wave carbon dioxide laser: some experimental observations. Am Surg (1968) 1.05
Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Respir Dis Suppl (1982) 1.04
What do we mean by "usually"? Lancet (1980) 1.03
Homocysteine and peripheral arterial disease: systematic review and meta-analysis. Eur J Vasc Endovasc Surg (2009) 1.03
Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol (1995) 1.03
The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. Int J Addict (1991) 1.02
A double-blind study of disodium cromoglycate for prophylaxis of bronchial asthma. Am Rev Respir Dis (1971) 1.02
A population survey on legislative measures to restrict smoking in Ontario: 2. Knowledge, attitudes, and predicted behavior. Am J Prev Med (1988) 1.01
The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology (1989) 1.00
Utility of behavioral self-help manuals in a minimal-contact smoking cessation program. Int J Addict (1981) 0.98
Change in smoking status among a cohort of late adolescents: prediction and explanation of initiation, maintenance and cessation. Int J Epidemiol (1986) 0.97
The health risks of passive smoking. The growing case for control measures in enclosed environments. Chest (1983) 0.97
Adjunct therapy in chronic obstructive pulmonary disease. Am J Med (1973) 0.97
A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Can Respir J (2000) 0.97
The care of the terminally ill: morality and economics. N Engl J Med (1983) 0.97
Interaction of glucocorticoids and bronchodilators on isolated guinea pig tracheal and human bronchial smooth muscle. Am Rev Respir Dis (1974) 0.95
Screening for diabetic retinopathy using computer based image analysis and statistical classification. Comput Methods Programs Biomed (2000) 0.95
Particulates in domestic premises. II. Ambient levels and indoor-outdoor relationships. Arch Environ Health (1975) 0.95
Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes. Eur J Clin Pharmacol (1990) 0.93
The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis. A double-blind single dose study. Chest (1982) 0.93
Pharmacological study of adenosine and related compounds on isolated guinea pig trachea: evidence for more than one type of purine receptor. Can J Physiol Pharmacol (1980) 0.93
Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler. J Allergy Clin Immunol (1997) 0.93
Toward an expanded vision of clinical ethics education: from the individual to the institution. Kennedy Inst Ethics J (1991) 0.92
Toward justice in health care. Am J Public Health (1988) 0.92
Ethical challenges of chronic illness. Hastings Cent Rep (1988) 0.91
Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model. J Allergy Clin Immunol (1997) 0.91
Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol (1982) 0.90
A study of the mechanism of the antiasthmatic action of inhaled budesonide. J Allergy Clin Immunol (1990) 0.89
Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society. Eur Respir J (1998) 0.89
Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii. Am Rev Respir Dis (1993) 0.88
Long-acting contraceptives. Ethical guidance for policymakers and health care providers. Hastings Cent Rep (1995) 0.88
Respiratory smooth muscle relaxing effect of commercial steroid preparations. Am Rev Respir Dis (1973) 0.88
Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisone. J Allergy Clin Immunol (1978) 0.88
Determinants of the response to beclomethasone aerosol at various dosage levels: a multiple regression analysis to identify clinically useful predictors. J Allergy Clin Immunol (1977) 0.88
Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis Suppl (1982) 0.88
Meta-analysis of the placebo-treated groups in clinical trials of progressive MS. Neurology (1996) 0.88
Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol (1989) 0.88
Predictors of 30-day hospital readmission after coronary artery bypass. Ann Thorac Surg (2000) 0.87
Psychological effects of an exercise program for post-infarct and normal adult men. J Sports Med Phys Fitness (1967) 0.87
Does cigarette smoking affect the fitness of young adults? Rationale and protocol for future research. J Sports Med Phys Fitness (1992) 0.86
Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study. Arch Neurol (1996) 0.86
New directions in nursing home ethics. Hastings Cent Rep (1991) 0.86